Biomark Diagnostics Inc. (CSE:BUX)
Canada
· Delayed Price · Currency is CAD 0.4750
-0.0050 (-1.04%)
At close: Dec 5, 2025
Biomark Diagnostics Cash Flow Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | -1.65 | -1.93 | -1.43 | -1.84 | -1.45 | -1.09 | Upgrade
|
| Depreciation & Amortization | 0.47 | 0.4 | 0.39 | 0.39 | 0.18 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.01 | Upgrade
|
| Stock-Based Compensation | 0.07 | 0.37 | 0.08 | 0.33 | - | 0.4 | Upgrade
|
| Other Operating Activities | 0.04 | 0.06 | 0.06 | 0.07 | 0.03 | -0 | Upgrade
|
| Change in Accounts Receivable | -0.11 | -0.12 | -0.01 | 0.05 | -0.05 | -0.01 | Upgrade
|
| Change in Accounts Payable | -0.21 | 0.12 | -0.08 | 0.09 | 0.11 | -0.08 | Upgrade
|
| Change in Other Net Operating Assets | -0.02 | -0 | - | - | -0.02 | -0.02 | Upgrade
|
| Operating Cash Flow | -1.41 | -1.09 | -0.98 | -0.91 | -1.2 | -0.81 | Upgrade
|
| Capital Expenditures | -0.01 | -0 | -0 | -0.01 | -0.06 | - | Upgrade
|
| Investment in Securities | -0.82 | - | - | - | - | -0 | Upgrade
|
| Investing Cash Flow | -0.84 | -0 | -0 | -0.01 | -0.06 | -0 | Upgrade
|
| Short-Term Debt Issued | - | 0.38 | 0.36 | 0.44 | 0.51 | 0.35 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.1 | Upgrade
|
| Total Debt Issued | 0.38 | 0.38 | 0.36 | 0.44 | 0.51 | 0.45 | Upgrade
|
| Short-Term Debt Repaid | - | -0.15 | -0.77 | -0.45 | -0.33 | -0.42 | Upgrade
|
| Long-Term Debt Repaid | - | -0.41 | -0.41 | -0.38 | -0.31 | -0.01 | Upgrade
|
| Total Debt Repaid | -0.63 | -0.57 | -1.18 | -0.83 | -0.64 | -0.43 | Upgrade
|
| Net Debt Issued (Repaid) | -0.25 | -0.19 | -0.82 | -0.39 | -0.13 | 0.02 | Upgrade
|
| Issuance of Common Stock | 3.19 | 3.61 | 1.89 | 1 | 0.9 | 1.06 | Upgrade
|
| Financing Cash Flow | 2.93 | 3.42 | 1.07 | 0.61 | 0.77 | 1.08 | Upgrade
|
| Net Cash Flow | 0.69 | 2.33 | 0.08 | -0.31 | -0.49 | 0.27 | Upgrade
|
| Free Cash Flow | -1.42 | -1.1 | -0.99 | -0.92 | -1.26 | -0.81 | Upgrade
|
| Free Cash Flow Margin | -1151.45% | -711.12% | -604.65% | -599.20% | -2875.13% | - | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | Upgrade
|
| Cash Interest Paid | 0.06 | 0.06 | 0.06 | 0.07 | 0.03 | 0 | Upgrade
|
| Levered Free Cash Flow | -0.91 | -0.55 | -0.71 | -0.36 | -0.66 | -1.3 | Upgrade
|
| Unlevered Free Cash Flow | -0.88 | -0.51 | -0.67 | -0.29 | -0.64 | -1.3 | Upgrade
|
| Change in Working Capital | -0.33 | 0 | -0.09 | 0.14 | 0.04 | -0.11 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.